Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer
Authors:
- 15 September 1985
- Vol. 56 (6) , 1332-1336
Abstract
One hundred eleven patients with inoperable but limited‐stage small cell lung cancer were treated with three courses of cyclophosphamide (1.5, 2.5, and 3.5 g/m2, respectively) and VP‐16‐213 followed by methotrexate and thoracic radiotherapy. The total duration of treatment was 3 months. Patients were included who had pleural effusions, contralateral neck nodes, and bone marrow infiltration. The complete response (CR) rate was 56%, the majority confirmed by repeat bronchoscopy, with an 81% overall response rate. The minimum follow‐up was 14 months. Median survival for all 111 patients was 11 months and 14 months (1–34+) for complete responders; the median survival was also 11 months for the 91 patients with conventional limited‐stage disease, although 15 of the 19 patients alive at 14 months or more were from this subpopulation. There was no significant difference in the survival of those CR patients whose response was confirmed bronchoscopically and patients whose CR was assessed only radiologically and clinically. Forty‐four patients with leukopenia (<1000 cells/μl) received intravenous antibiotics for malaise and suspected infection. Close monitoring between treatments and direct access of patients to the hospital was encouraged. The majority of patients improved symptomatically as assessed by Karnofsky and Respiratory scores. These results support the view that short but intensive treatment without long‐term or maintenance chemotherapy is beneficial.Keywords
This publication has 12 references indexed in Scilit:
- Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancerRespiratory Medicine, 1984
- Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial.BMJ, 1984
- VP-16 plus cyclophosphamide in the treatment of advanced lung cancerCancer, 1983
- Intermittent high-dose cyclophosphamide with and without prednisolone. A study of the relationships between toxicity, response and survival in metastatic lung cancerCancer, 1982
- 11-WEEK COURSE OF SEQUENTIAL METHOTREXATE, THORACIC IRRADIATION, AND MODERATE-DOSE CYCLOPHOSPHAMIDE FOR "LIMITED"-STAGE SMALL-CELL BRONCHOGENIC CARCINOMAThe Lancet, 1982
- VP16-213 (Etoposide)Cancer Chemotherapy and Pharmacology, 1982
- Small cell carcinoma of the lungBlood, 1980
- Small-cell lung cancerCancer Chemotherapy and Pharmacology, 1980
- Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung.British Journal of Cancer, 1979
- “Total” therapy for oat cell carcinoma of the lungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1977